-

Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM

New solution uses automated 3D metrology to increase productivity in fabrication environments

WALTHAM, Mass.--(BUSINESS WIRE)--From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on complicated structures at the atomic scale within silicon chips. As these chips increase in processing power and decrease in size, even the smallest fault can cause massive delays.

To help chipmakers keep pace and minimize delays, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Helios™ MX1 Plasma Focused Ion Beam (PFIB) Scanning Electron Microscope (SEM). This system enables chip manufacturers to visualize and analyze buried semiconductor structures directly within fabrication (fab) environments.

Helios MX1 uses automated 3D reconstruction and metrology to significantly enhance the analysis of semiconductor logic, memory and advanced packaging devices. This fully automated wafer analysis system is uniquely designed to increase productivity in the fab by accelerating time-to-data — the speed at which engineers can see and understand what’s happening deep within a semiconductor.

Seeing the unseen
By integrating high-resolution laboratory instrumentation into the fab environment, Helios MX1 quickly reveals details that were previously only achievable in a lab. This accelerates time-to-yield by providing fast, accurate and valuable insights into semiconductor subsurface defects.

“With Helios MX1, semiconductor fab engineers can now see what was previously only visible in a laboratory,” said Mohan Iyer, semiconductor vice president and general manager at Thermo Fisher Scientific. “The semiconductor industry is witnessing a dramatic increase in the amount of analysis needed within fabrication environments, and traditional methods are no longer sufficient. With Helios MX1, our customers can now have a detailed, three-dimensional look at structures that are beneath the wafer surface.”

Thermo Fisher Scientific proudly offers the Helios MX1 to unlock the potential of fab-ready 3D process control and optimize semiconductor production. This unique solution is designed to enable semiconductor customers to improve medical devices, advance automated vehicles, enhance AI computing and more.

Learn more about the Thermo Scientific Helios MX1 PFIB-SEM on our website.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Alex Runner, Thermo Fisher Scientific
336-259-4653
alex.runner@thermofisher.com

Media Contact Information:
Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Alex Runner, Thermo Fisher Scientific
336-259-4653
alex.runner@thermofisher.com

Media Contact Information:
Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies. Accelerating Drug Discovery with Cryo-EM The...

Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar**, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species — including Candida auris, a growing global antimicrobial resistance (AMR) threat1. Invasive fungal infections are an increasing challenge for healthcare systems w...

Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner

WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection. For transplant recipients, finding the right tacrolimus dose as early as possible can be life-changing. If the dose is too low, the body may...
Back to Newsroom